BACTERIOSTATIC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bacteriostatic, and when can generic versions of Bacteriostatic launch?
Bacteriostatic is a drug marketed by Abraxis Pharm, Fresenius Kabi Usa, and Hospira. and is included in six NDAs.
The generic ingredient in BACTERIOSTATIC is sterile water for injection. There are one thousand and seventy-two drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the sterile water for injection profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bacteriostatic
A generic version of BACTERIOSTATIC was approved as sterile water for injection by HOSPIRA on October 27th, 1982.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BACTERIOSTATIC?
- What are the global sales for BACTERIOSTATIC?
- What is Average Wholesale Price for BACTERIOSTATIC?
Summary for BACTERIOSTATIC
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 6 |
| DailyMed Link: | BACTERIOSTATIC at DailyMed |

